RxDoctor Payments Data

Lisa Holloway

Family Medicine · Houston, TXNPI 1548292360

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $2,838 of the $4,272 with a category attached, or 66.4%. Modernatx, Inc. accounts for 91.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $2,853 and has fallen 95.3% since, to $135 in 2025.

$4,272in general payments, 2019–2025

Across 39 payments — averaging $109.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$4K
  • Astrazeneca UK Limited$135
  • Gilead$102
  • Amarin Pharma, Inc.$47
  • Sanofi Pasteur Inc.$35
  • Bayer$23
  • plus $32 from 2 others
$30,060,090in research payments, 2019–2025

Across 6,916 payments — averaging $4346.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$24.9M
  • Pfizer$2.7M
  • Bavarian Nordic A/s$1.1M
  • AstraZeneca$564K
  • Sanofi Pasteur Inc.$447K
  • Seqirus USA Inc$358K

What the payments were for

  • Travel & lodging$2,83866%
  • Food & beverage$1,43434%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,272 in reported general payments places this provider in the 85th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Other family medicine in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →